JP2860963B2 - New substance SBS and method for producing the same - Google Patents
New substance SBS and method for producing the sameInfo
- Publication number
- JP2860963B2 JP2860963B2 JP21810490A JP21810490A JP2860963B2 JP 2860963 B2 JP2860963 B2 JP 2860963B2 JP 21810490 A JP21810490 A JP 21810490A JP 21810490 A JP21810490 A JP 21810490A JP 2860963 B2 JP2860963 B2 JP 2860963B2
- Authority
- JP
- Japan
- Prior art keywords
- sbs
- producing
- reaction
- novel substance
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、血小板凝集抑制作用及び抗発ガンプロモー
ター作用を有する新規物質SBS及びその製造方法に関す
る。Description: TECHNICAL FIELD The present invention relates to a novel substance SBS having a platelet aggregation inhibitory action and an antitumor promoter action, and a method for producing the same.
近年、担子菌類からの生理活性物質検索が盛んであ
り、様々な報告がなされている。例えば、カワラタケや
スエヒロタケから抗腫瘍性物質が、マンネンタケから血
圧降下物質が見出され、その他にも種々の担子菌類より
免疫賦活物質、抗アレルギー物質、抗潰瘍物質等が見出
されている。また、一般に常食されているきのこからも
薬理作用が見出されており、シイタケやエノキタケより
抗腫瘍性物質が、ヒラタケより血圧降下作用(特開平2
−72121号公報)が知られている。また、文部省の特定
研究「食品機能の系統的解析と展開」を切掛けとして食
品の3次機能をうたった機能性食品が現在注目されてお
り、日常摂取している食品の生体調節機能の研究及び食
品中の生理活性物質の検索も盛んに行われている。In recent years, bioactive substances from basidiomycetes have been actively searched for, and various reports have been made. For example, antitumor substances have been found from Kawatake mushroom and Suehirotake mushroom, blood pressure lowering substances have been found from Mannake mushroom, and immunostimulants, antiallergic substances, antiulcer substances and the like have been found from various basidiomycetes. Pharmacological effects have also been found in mushrooms that are commonly eaten, and antitumor substances are more effective than shiitake mushrooms and enokitake and blood pressure lowering effects than oyster mushrooms (Japanese Unexamined Patent Publication No.
-72121). In addition, a special research conducted by the Ministry of Education, “Systematic Analysis and Development of Food Functions,” has triggered the attention of functional foods that claim to be tertiary functions of foods. Searches for physiologically active substances in foods have also been actively conducted.
本発明の目的は、シイタケ、エノキタケと並び食品き
のことして常食されているリオフイラム ウルマリウム
の産生する新規生理活性物質及びその製造方法を提供す
ることにある。An object of the present invention is to provide a novel physiologically active substance produced by Liophyllum ulmarium, which is eaten as a food mushroom along with Shiitake mushroom and Enokitake mushroom, and a method for producing the same.
本発明を概説すれば、本発明の第1の発明は新規物質
SBSに関し、下記の理化学的物質を有することを特徴と
する。In summary, the first invention of the present invention is a novel substance
SBS is characterized by having the following physicochemical substances.
元素分析:C 73.06% H 11.85% 分子量:738(FAB−マススペクトルによる) 分子式:C45H86O7 紫外部吸収スペクトル(メタノール中):第1図に示
すように208nmに極大吸収を示す。Elemental analysis: C 73.06% H 11.85% Molecular weight: 738 (according to FAB-mass spectrum) Molecular formula: C 45 H 86 O 7 ultraviolet absorption spectrum (in methanol): shows a maximum absorption at 208 nm as shown in FIG.
赤外部吸収スペクトル(KBr錠):第2図に示すよう
に3400、2990、2960、2920、1380、1180、945cm-1に吸
収を示す。Infrared absorption spectrum (KBr tablet): As shown in FIG. 2, absorption is shown at 3400, 2990, 2960, 2920, 1380, 1180, and 945 cm −1 .
呈色反応:ニンヒドリン反応陰性、フェノール硫酸反
応陰性、ヨウ素反応陽性、過マンガン酸カリウムウ脱色
反応陽性 また、本発明の第2の発明は、新規物質SBSの製造方
法に関し、リオフイラム属に属する新規物質SBS生産菌
の培養物又は該生産菌の子実体より、第1の発明の新規
物質SBSを採取することを特徴とする。Color reaction: negative for ninhydrin reaction, negative for phenol sulfate reaction, positive for iodine reaction, positive for decolorization reaction of potassium permanganate Further, the second invention of the present invention relates to a method for producing a novel substance SBS, and a novel substance SBS belonging to the genus Liofiram. The novel substance SBS of the first invention is collected from a culture of a producing bacterium or a fruit body of the producing bacterium.
本発明の1例を示すと、新規物質SBS生産菌の子実体
としては、商品名「やまびこほんしめじ 」として大量
に人工栽培・市販されているものが利用できる。また菌
株の培養物の例としては、リオフイラム ウルマリウム
Lu1−8(FERM BP−1416)の培養物が利用でき、本菌
株の微生物学的性質は、特開昭63−273467号公報に記載
されているが、本発明に使用される新規物質SBS生産菌
は上記菌株に限らず、リオフイラム属に属する菌株であ
ればどのような菌株でも用いることができる。 As an example of the present invention, the fruiting body of a novel substance SBS-producing bacterium
As for the product name "Yamabiko "
Artificially cultivated and commercially available can be used. Also fungus
Examples of strain cultures include Liofiram ulmarium
A culture of Lu1-8 (FERM BP-1416) is available.
The microbiological properties of the strain are described in JP-A-63-273467.
The novel substance used in the present invention SBS-producing bacteria
Is a strain belonging to the genus Liophyllam, not limited to the above strains.
Any strain can be used.
新規物質SBSの製造方法は、子実体又は培養菌体の取
得、抽出、精製の3工程からなる。子実体は市販品が容
易に入手可能であり、培養菌体は、一般的な液体培養法
により得られる。例えば、炭素源としてグルコース、ス
クロース、デンプン、デキストリン、グリセリン、油脂
類など資化しうる有機炭素類、窒素源として酵母エキ
ス、ペプトン、コーンスチープリカー、脱脂大豆、大豆
皮、肉エキス、アミノ酸、アンモニウム塩などの有機窒
素化合物や無機窒素化合物が利用できる。そのほかに、
マグネシウム塩、リン酸塩、カリウム塩等の無機塩類を
加えてもよい。培養温度は、15〜30℃が適当であり、20
〜25℃が好ましい。培養pHは、5〜9が適当であり、7
〜8付近が好ましい。培養は、振とう培養、静置培養ど
ちらでもよく、5〜15日で菌体が得られるが、静置培養
のほうがSBSの生産量は高い。次に抽出は、メタノー
ル、エタノール、アセトン、酢酸エチル、クロロホルム
等の有機溶媒を用いて行われる。精製は、順相及び逆相
シリカゲル、逆相ODS、セルロース等の吸着クロマトグ
ラフィー、ゲルろ過法、各種溶媒に対する溶解度の差を
利用する方法等の一般的な分離精製法を用いることがで
きる。The method for producing the novel substance SBS comprises three steps of obtaining, extracting and purifying fruit bodies or cultured cells. The fruiting body is easily available as a commercial product, and the cultured cells are obtained by a general liquid culture method. For example, glucose, sucrose, starch, dextrin, glycerin, organic carbons such as fats and oils that can be used as a carbon source, yeast extract, peptone, corn steep liquor, defatted soybean, soybean hull, meat extract, amino acid, ammonium salt as a nitrogen source Organic nitrogen compounds and inorganic nitrogen compounds can be used. Besides that,
Inorganic salts such as magnesium salts, phosphates and potassium salts may be added. The culture temperature is suitably 15-30 ° C,
~ 25 ° C is preferred. The culture pH is suitably from 5 to 9;
~ 8 is preferred. The culture may be either shaking culture or static culture, and cells can be obtained in 5 to 15 days. However, static culture produces higher SBS. Next, extraction is performed using an organic solvent such as methanol, ethanol, acetone, ethyl acetate, and chloroform. For purification, general separation and purification methods such as adsorption chromatography of normal-phase and reverse-phase silica gel, reverse-phase ODS, cellulose and the like, gel filtration, and a method utilizing a difference in solubility in various solvents can be used.
以上のようにして得られた新規物質SBSは、次の理化
学的性質を有する。The novel substance SBS obtained as described above has the following physicochemical properties.
1. 外観:白色粉末 2. 元素分析:C 73.06% H 11.85% 3. 分子量(FABマススペクトルによる):738 4. 分子式:C45H86O7 5. 比旋光度:〔α〕D 20=+5.4゜(c=1.0、メタノ
ール) 6. 紫外部吸収スペクトル(メタノール中):第1図に
示すように208nmに極大吸収を示す。すなわち、第1図
は本物質を0.25mg/mlの濃度でメタノール中に溶解させ
た場合の紫外部吸収スペクトルを吸光度(縦軸)と波長
(nm、横軸)との関係で示す図である。1. Appearance: white powder 2. Elemental analysis: C 73.06% H 11.85% 3. Molecular weight (according to FAB mass spectrum): 738 4. Molecular formula: C 45 H 86 O 7 5. Specific rotation: [α] D 20 = + 5.4 ° (c = 1.0, methanol) 6. Ultraviolet absorption spectrum (in methanol): shows a maximum absorption at 208 nm as shown in FIG. That is, FIG. 1 is a diagram showing an ultraviolet absorption spectrum in the case where this substance is dissolved in methanol at a concentration of 0.25 mg / ml in a relationship between absorbance (vertical axis) and wavelength (nm, horizontal axis). .
7. 赤外部吸収スペクトル(KBr錠):第2図に示すよ
うに、3400、2990、2960、2920、1380、1180、945cm-1
に吸収を示す。すなわち第2図は、本物質のKBr錠の赤
外部吸収スペクトルを透過率(%、縦軸)と波数(c
m-1、横軸)との関係で示す図である。7. Infrared external absorption spectrum (KBr tablet): As shown in Fig. 2, 3400, 2990, 2960, 2920, 1380, 1180, 945cm -1
Shows absorption. That is, Fig. 2 shows the infrared absorption spectrum of the KBr tablet of this substance in terms of transmittance (%, vertical axis) and wave number (c
m- 1 (horizontal axis).
8. 呈色反応:ニンヒドリン反応は陰性、フェノール硫
酸反応では糖の呈色性を示さず。ヨウ素反応及び過マン
ガン酸カリウム脱色反応では陽性。8. Color reaction: Ninhydrin reaction is negative, and phenol sulfate reaction does not show sugar color. Positive in iodine reaction and potassium permanganate decolorization reaction.
9. 溶解性:メタノール、アセトン、クロロホルム、酢
酸エチルに可溶、水、ヘキサンに難溶 10. 酸性、中性、塩基性の区別:中性 上記理化学的性質に一致する既知物質は報告されてい
ないので、SBSは新規物質であると決定した。9. Solubility: Soluble in methanol, acetone, chloroform and ethyl acetate, poorly soluble in water and hexane 10. Distinguishing between acidic, neutral and basic: neutral Known substances that match the above physicochemical properties have been reported. As such, SBS was determined to be a new substance.
次に本発明の新規物質SBSの生理活性を実験例により
示す。Next, the physiological activity of the novel substance SBS of the present invention will be described by experimental examples.
実験例1 血小板凝集抑制作用 血小板凝集じゃく起物質として最終濃度5μg/mlのコ
ラーゲンを用いた。日本白色種ウサギ血小板(4×105/
μ)0.2mlに、最終濃度1〜50μg/mlの新規物質SBSを
添加し、その30秒後にコラーゲンを添加して血小板の凝
集を観察した。その結果、以下の第1表に示す通り、新
規物質SBSは、明らかな血小板凝集抑制作用を有してい
た。EXPERIMENTAL EXAMPLE 1 Platelet Aggregation Inhibition Collagen having a final concentration of 5 μg / ml was used as a platelet aggregation-causing substance. Japanese white rabbit platelets (4 × 10 5 /
μ) To 0.2 ml, a novel substance SBS having a final concentration of 1 to 50 μg / ml was added, and 30 seconds later, collagen was added, and aggregation of platelets was observed. As a result, as shown in Table 1 below, the novel substance SBS had a clear platelet aggregation inhibitory action.
実験例2 抗発ガンプロモーター作用 発ガンプロモーターテレオシジンB−4(Teleocidin
B−4)が誘導するエプシュタイン−バール(Epstein
−Barr)ウイルスの早期抗原を抑制する効果をラジ(Ra
ji)細胞を用いたイン ビトロ(in vitro)の系で試験
した。 Experimental Example 2 Anticancer Promoter Action Carcinogenic Promoter Teleocidin B-4 (Teleocidin
B-4) Induced Epstein-Burl (Epstein)
-Barr: The effect of suppressing the early antigen of the virus
ji) Tested in an in vitro system using cells.
ラジ細胞(5×105/ml)を、20ng/mlテレオシジンB
−4、ジメチルスルホキシド5μ及び3mM n−酪酸
を含む培地で48時間培養し、早期抗原を誘導した細胞を
間接免疫蛍光法により検出した。同様にして、新規物質
SBSを最終濃度2μg/ml添加したものと比較したとこ
ろ、無添加に比べ早期抗原を誘導した細胞数は、40%に
抑えられた。この結果、新規物質SBSに抗発ガンプロモ
ーター作用があることが明らかとなった。Raji cells (5 × 10 5 / ml) were converted to 20 ng / ml teleocidin B
-4, cultivated in a medium containing 5 μm of dimethylsulfoxide and 3 mM n-butyric acid for 48 hours, and cells in which an early antigen was induced were detected by indirect immunofluorescence. Similarly, new substances
As compared with the case where SBS was added at a final concentration of 2 μg / ml, the number of cells that induced the antigen earlier was suppressed to 40% as compared with the case where SBS was not added. As a result, it was revealed that the novel substance SBS has an anti-cancer promoter action.
実験例3 急性毒性試験 ICRマウスに本発明の新規物質を経口投与した。1000m
g/kg投与において毒性は認められなかった。Experimental Example 3 Acute toxicity test The novel substance of the present invention was orally administered to ICR mice. 1000m
No toxicity was observed at g / kg administration.
以上、本発明の物質は、以上の実験例に示した通り、
血小板凝集抑制作用、抗発ガンプロモーター作用を示
し、抗血栓剤、抗発ガン剤等として有用である。As described above, the substance of the present invention, as shown in the above experimental examples,
It exhibits platelet aggregation inhibitory action and anticancer promoter action, and is useful as an antithrombotic agent, an anticancer agent and the like.
また、本物質は、リンパ球のコンカナバリンAによる
幼若化反応を抑制し、抗アレルギー剤としても有用であ
る。The substance also suppresses the blastogenesis of lymphocytes by concanavalin A, and is also useful as an antiallergic agent.
次に、実施例を挙げて本発明を更に具体的に説明する
が、本発明は以下の実施例の範囲に限定されるものでは
ない。Next, the present invention will be described more specifically with reference to examples, but the present invention is not limited to the scope of the following examples.
実施例1 「やまびこほんしめじ 」の子実体1.5kgを凍結乾燥
し、粉砕機で微粉末とした。酢酸エチル3を加えかく
はんしながら3時間抽出し、抽出物5.4gを得た。この抽
出物を少量のクロロホルムに溶かし、75gのシリカゲル6
0(メルク社製)を充てんしクロロホルムで洗浄したカ
ラムに付した。1のクロロホロムで洗浄後、クロロホ
ルム−メタノール(4:1,V/V)溶液で溶出し、溶出物1.1
gを得た。この溶出物を分取用逆相高速液体クロマトグ
ラフィー〔カラム:カプセルパックC18,φ10×250mm,資
生堂製 移動相:メタノール−水(4:1,V/V)〕に付
し、第3図のクロマトパターンを得た。すなわち、第3
図は逆相高速液体クロマトグラフィーのクロマトパター
ンを示す図であり、縦軸は吸光度(210nm)、横軸は時
間(分)を示す。Example 1 Freeze-dried 1.5 kg of fruiting body
Then, it was pulverized into fine powder with a pulverizer. Add ethyl acetate 3
Extraction was performed for 3 hours while stirring to obtain 5.4 g of an extract. This extraction
Dissolve the product in a small amount of chloroform and use 75 g of silica gel 6
0 (manufactured by Merck) and washed with chloroform
Attached to the ram. After washing with 1 chlorophorom,
Eluted with LUM-methanol (4: 1, V / V) solution.
g was obtained. This eluate is subjected to preparative reversed-phase high-performance liquid chromatography.
Raffy [Column: Capsule Pack C18, φ10 × 250mm, capital
Mobile phase: methanol-water (4: 1, V / V)
Then, the chromatographic pattern shown in FIG. 3 was obtained. That is, the third
The figure shows the chromatographic pattern of reversed-phase high-performance liquid chromatography.
The vertical axis represents absorbance (210 nm), and the horizontal axis represents time.
Indicates the interval (minute).
第3図のそれぞれの画分を分取し、A:18mg、:B:39m
g、C:44mg、D:38mg、E:56mg、F:61mg、G:48mg及びSBS:1
06mgを得た。Each fraction of FIG. 3 was fractionated, A: 18 mg,: B: 39 m
g, C: 44 mg, D: 38 mg, E: 56 mg, F: 61 mg, G: 48 mg and SBS: 1
06 mg was obtained.
実施例2 リオフイラム ウルマリウムLu1−8(FERM BP−141
6)株の斜面培地より100mlの種培地(グルコース2%、
酵母エキス0.3%、ペプトン0.5%、KH2PO4の0.1%、MgS
O4・7H2Oの0.05%)を入れた500ml用三角フラスコに接
種し、25℃で14日間振とう培養して種培養液を得た。こ
の種培養液200mlを、10の生産培地(種培地と同組
成)を入れた30容ジャーファーメンターに接種し、25
℃、6日間通気かくはん培養(通気量10/分、かくは
ん200rpm)を行った。フィルタープレスで集菌し、湿菌
体830gを得た。この菌体を凍結乾燥後、実施例1と同様
の操作により、SBS49mgを得た。Example 2 Liophylum ulmarium Lu1-8 (FERM BP-141
6) 100 ml of seed medium (2% glucose,
Yeast extract 0.3%, peptone 0.5%, KH 2 PO 4 0.1%, MgS
O 4 · 7H 2 0.05% of O) was inoculated into 500ml Erlenmeyer flasks containing, to obtain a seed culture solution was cultured with shaking for 14 days at 25 ° C.. 200 ml of this seed culture was inoculated into a 30-volume jar fermenter containing 10 production media (same composition as the seed medium), and 25
Aeration and agitation culture (aeration 10 / min, agitation 200 rpm) was performed at 6 ° C for 6 days. The cells were collected by a filter press to obtain 830 g of wet cells. After freeze-drying the cells, 49 mg of SBS was obtained in the same manner as in Example 1.
実施例3 実施例1で得た各画分の血小板凝集抑制作用及び抗発
ガンプロモーター作用を調べたところ、第2表の結果を
得た。血小板凝集抑制作用は、凝集剤としてコラーゲン
を用いたイン ビトロ系で検定し、抗発ガンプロモータ
ー作用は、発ガンプロモーターによるエプシュタイン−
バールウイルス活性化の抑制で検定した。Example 3 The platelet aggregation inhibitory action and the anti-cancer promoter action of each fraction obtained in Example 1 were examined, and the results shown in Table 2 were obtained. The effect of inhibiting platelet aggregation was assayed in an in vitro system using collagen as an aggregating agent.
The assay was performed by suppressing the activation of the bur virus.
(表中、+は活性の強さを表し、その強さは++++
>+++>++>+ の順である。また、−は活性がな
いことを示す) 〔発明の効果〕 本発明のSBSは、食用菌リオフィラム ウルマリウム
等によって生産される新規物質であり、血小板凝集抑制
作用及び抗発ガンプロモーター作用を有することから、
機能性食品素材等として有用である。 (In the table, + represents the intensity of activity, and the intensity is +++++
>++++>++> ++. In addition,-indicates no activity) [Effect of the Invention] The SBS of the present invention is a novel substance produced by the edible bacterium Liophyllum ulmarium and the like, and has a platelet aggregation inhibitory action and an anti-cancer promoter action. ,
It is useful as a functional food material.
第1図は新規物質SBSの紫外部吸収スペクトルを示す
図、第2図は同物質の赤外部吸収スペクトル(KBr錠)
を示す図、第3図は、同物質の逆相高速液体クロマトグ
ラフィーの結果を示す図である。Fig. 1 shows the UV absorption spectrum of the novel substance SBS, and Fig. 2 shows the infrared absorption spectrum of the same substance (KBr tablets).
FIG. 3 shows the results of reversed-phase high-performance liquid chromatography of the same substance.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C12R 1:645) (72)発明者 森田 日出男 滋賀県大津市瀬田3丁目4番1号 寳酒 造株式会社中央研究所内 (72)発明者 大東 肇 京都府京都市山科区御陵大岩町19番地 (72)発明者 小清水 弘一 奈良県奈良市法蓮山添西町856番地10──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 6 Identification code FI C12R 1: 645) (72) Inventor Morio Hideo 3-4-1 Seta, Otsu-shi, Shiga Pref. 72) Inventor: Hajime Daito 19, Goryo Oiwa-cho, Yamashina-ku, Kyoto, Kyoto (72) Inventor: Koichi Koshimizu 856-10, Horiyamazoe Nishicho, Nara City, Nara Prefecture
Claims (2)
S。 元素分析:C 73.06% H 11.85% 分子量:738(FAB−マススペクトルによる) 分子式:C45H86O7 紫外部吸収スペクトル(メタノール中):208nmに極大吸
収 赤外部吸収スペクトル(KBr錠):3400、2990、2960、29
20、1380、1180、945cm-1 呈色反応:ニンヒドリン反応陰性、フェノール硫酸反応
陰性、ヨウ素反応陽性、過マンガン酸カリウム脱色反応
陽性1. A new substance SB having the following physicochemical properties:
S. Elemental analysis: C 73.06% H 11.85% Molecular weight: 738 (by FAB-mass spectrum) Molecular formula: C 45 H 86 O 7 Ultraviolet absorption spectrum (in methanol): Maximum absorption at 208 nm Red external absorption spectrum (KBr tablet): 3400 , 2990, 2960, 29
20, 1380, 1180, 945cm -1 Color reaction: Ninhydrin reaction negative, phenol sulfate reaction negative, iodine reaction positive, potassium permanganate decolorization reaction positive
菌の培養物又は該生産菌の子実体より、請求項1記載の
新規物質SBSを採取することを特徴とする新規物質SBSの
製造方法。2. A method for producing a novel substance SBS, which comprises collecting the novel substance SBS according to claim 1 from a culture of a novel substance SBS-producing bacterium belonging to the genus Lyophyllam or a fruiting body of said producing bacterium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21810490A JP2860963B2 (en) | 1990-08-21 | 1990-08-21 | New substance SBS and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21810490A JP2860963B2 (en) | 1990-08-21 | 1990-08-21 | New substance SBS and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04104795A JPH04104795A (en) | 1992-04-07 |
| JP2860963B2 true JP2860963B2 (en) | 1999-02-24 |
Family
ID=16714698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21810490A Expired - Lifetime JP2860963B2 (en) | 1990-08-21 | 1990-08-21 | New substance SBS and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2860963B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005115364A1 (en) * | 2004-05-31 | 2005-12-08 | Takara Bio Inc. | Antitumor agent |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007018095A1 (en) * | 2005-08-09 | 2007-02-15 | Takara Bio Inc. | Method of producing extract derived from hypsizigus marmoreus |
-
1990
- 1990-08-21 JP JP21810490A patent/JP2860963B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005115364A1 (en) * | 2004-05-31 | 2005-12-08 | Takara Bio Inc. | Antitumor agent |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04104795A (en) | 1992-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1046439A (en) | Physiologically active substances from penicillium citrinum | |
| JP2013540769A (en) | Fructosylated puerarin and its preparation and use | |
| JP2860963B2 (en) | New substance SBS and method for producing the same | |
| JPH0447648B2 (en) | ||
| CN103275139B (en) | 16 carbon diacetyl one double bond lactone type sophorolipid and application thereof | |
| CN103275138B (en) | 16 carbon diacetyls are without double bond lactone type sophorolipid and application thereof | |
| US3907764A (en) | Pepsinostrepins, novel protease inhibitors from streptomyces | |
| CN103275140B (en) | The two key lactone type sophorolipids of 18 one of carbon diacetyl and application thereof | |
| JPS63209579A (en) | Cultivation of cordyceps sinensis sacc. | |
| US6004995A (en) | Macrolide compound 0406 | |
| JP3066166B2 (en) | Novel compound HC34, its use and production | |
| JP4608651B2 (en) | Compound having anticancer activity, process for producing the same and anticancer agent | |
| JP2578486B2 (en) | New substance KS-502 | |
| JPH029382A (en) | Novel antibiotic ikd-8344 substance and production thereof and antitumor agent with the same substance as active ingredient | |
| JPH08239379A (en) | Kr 2827 derivative as new substance, its production and use | |
| JP3062321B2 (en) | Novel compound RGT-1, method for producing the same, and antitumor agent containing the compound as an active ingredient | |
| CN104497001A (en) | Curcumenol microbial conversion derivative, and preparation method and use thereof | |
| JP2001002613A (en) | New monoterpene-based compound bmt | |
| JP2001011075A (en) | New dioxopiperazine derivative | |
| JPH09241287A (en) | Novel collagenase inhibitor FO-5904 and method for producing the same | |
| JP2000060584A (en) | New physiological active substance na33, 414a and na33, 414b, their production and use | |
| JPH01256393A (en) | Novel compound nonahydrin | |
| JPH09309861A (en) | New anthraquinone-based compound 0089 | |
| JPH05213758A (en) | Blood platelet increasing agent | |
| JPH05221867A (en) | Il-6 inducer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071211 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081211 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081211 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20091211 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20101211 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20101211 |